Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
National Institute of Immunology, Aruna Asaf Ali Marg, Jawaharlal Nehru University, New Delhi, Delhi, India.
Adv Exp Med Biol. 2018;1112:245-254. doi: 10.1007/978-981-13-3065-0_17.
Neuropathic pain arises because of neuronal injury. Unlike inflammatory pain which can be managed by classical nonsteroid anti-inflammatory drugs (NSAIDs), neuropathic pain is difficult to treat. The classical NSAIDs work through inhibition of cyclooxygenase 2 (COX2) enzyme. However, COX2 inhibitors are insufficient to treat neuropathic pain. Hence, it becomes important to explore for novel molecules acting through cell surface molecules like ion channels, for the treatment of neuropathic pain. We investigated multiple bromobenzothiophene carboxamides for their efficacy against neuropathic pain. Interestingly, AS6 was found to be very effective in treating neuropathic pain through inhibition of Kv4.3 ion channel. AS6 also reduced the COX2 overexpression associated with neuropathic pain. These results as well as results from our previous study indicate that AS6 can be a potent antinociceptive agent against both inflammatory and neuropathic pain.
神经病理性疼痛是由于神经元损伤引起的。与可以通过经典非甾体抗炎药 (NSAIDs) 治疗的炎性疼痛不同,神经病理性疼痛难以治疗。经典的 NSAIDs 通过抑制环氧化酶 2 (COX2) 酶起作用。然而,COX2 抑制剂不足以治疗神经病理性疼痛。因此,探索通过细胞膜表面分子(如离子通道)作用的新型分子来治疗神经病理性疼痛变得非常重要。我们研究了多种溴苯并噻吩甲酰胺对神经病理性疼痛的疗效。有趣的是,发现 AS6 通过抑制 Kv4.3 离子通道非常有效地治疗神经病理性疼痛。AS6 还减轻了与神经病理性疼痛相关的 COX2 过表达。这些结果以及我们之前的研究结果表明,AS6 可以成为一种针对炎性和神经病理性疼痛的有效镇痛剂。